Charles River Laboratories International Cash Flow Statement (2009-2025) | CRL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Apr2023	Jul2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	63.94M	89.92M	105.16M	139.83M	95.23M	110.66M	97.61M	189.11M	103.95M	99.44M	88.02M	188.95M	74.48M	94.26M	70.30M	-213.75M	25.88M	52.69M	55.56M	-276.29M
Depreciation and Depletion (Quarter)	0.65M	0.72M	0.73M	138.59M	0.56M	0.57M	0.56M	155.62M	42.20M	43.40M	44.60M	46.50M	45.70M	47.60M	48.50M	48.40M	43.40M	44.30M	44.80M	45.10M
Share-based Compensation (Quarter)	13.19M	17.08M	22.02M	19.18M	14.62M	14.93M	22.00M	22.07M	13.46M	16.27M	22.80M	19.52M	16.74M	16.59M	19.33M	17.23M	13.13M	17.05M	23.27M	17.63M
Deferred Taxes (Quarter)	-9.12M	18.02M	-22.65M	-10.25M	-7.56M	-7.12M	-11.64M	-9.56M	-11.58M	-4.97M	-11.70M	-22.65M	-0.99M	-12.09M	-12.91M	-41.44M	-19.04M	-21.99M	25.91M	-60.17M
Cash from Discontinued Operations (Quarter)
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)			-0.93M	0.66M	4.45M	0.32M	-36.35M	15.46M	-1.45M	2.50M	0.99M	-3.12M	0.45M	-6.14M	6.05M	-4.91M	-0.10M	-0.24M	-2.96M	0.80M
Asset Writedowns and Impairment (Quarter)								6.71M	10.46M	-0.61M	16.35M	-7.98M	5.43M	8.82M	-6.03M	27.00M	2.01M	29.20M	-26.64M	7.88M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	170.23M	186.59M	174.72M	229.26M	102.63M	149.47M	132.78M	234.76M	109.38M	148.12M	205.45M	220.94M	129.89M	193.53M	251.79M	159.36M	171.70M	204.60M	213.83M	147.52M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	61.51M	68.11M	68.69M	67.24M	75.30M	76.42M	74.61M	77.55M	77.07M	77.67M	78.87M	80.51M	85.36M	86.08M	88.20M	102.10M	120.36M	119.51M	85.16M	78.28M
Change in Working Capital
Change in Receivables (Quarter)	-5.60M	10.82M	30.37M	-8.96M	57.94M	59.70M	56.53M	-23.60M	33.83M	14.42M	10.83M	-25.65M	17.28M	-18.35M	-17.23M	-3.31M	29.35M	-10.86M	-26.60M	-27.63M
Change in Inventory (Quarter)	11.40M	-4.30M	-1.47M	19.52M	23.16M	40.56M	12.56M	2.24M	8.59M	24.08M	11.46M	18.18M	-5.60M	-4.15M	-4.04M	-3.02M	21.88M	-7.93M	31.33M	3.50M
Change in Account Payables (Quarter)	9.62M	-23.00M	24.81M	33.47M	40.93M	-9.47M	-25.49M	-8.63M	-41.31M	16.33M	-1.55M	6.10M	-8.54M	2.10M	-0.66M	-7.18M	25.25M	-9.01M	24.51M	-37.88M
Change in Accured Expenses (Quarter)	-37.36M	51.29M	4.28M	26.09M	-79.80M	41.62M	5.44M	-9.43M	-21.47M	13.82M	36.09M	-15.99M	-20.95M	-12.21M	31.17M	-25.62M	15.26M	23.73M	42.88M	-2.56M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	5.01M	-4.50M	-15.52M	13.01M	12.08M	15.56M	-25.60M	-35.28M	-12.23M	5.43M	14.73M	-46.58M	19.96M	-11.81M	5.43M	4.96M	-1.21M	23.42M	43.07M	-103.42M
Investing Activities
Capital Expenditures (Quarter)	28.03M	46.43M	55.54M	98.78M	80.46M	82.85M	72.39M	89.02M	106.88M	67.38M	65.95M	78.32M	79.14M	39.49M	38.72M	75.62M	59.32M	35.30M	35.58M	88.95M
Acquisitions (Quarter)	94.20M	906.31M	291.59M	1.00M		283.39M			50.17M			144.62M		5.48M
Divestments (Quarter)																	17.44M
Change in Acquisitions & Divestments (Quarter)		5.20M	0.76M	0.57M	0.20M		2.90M	1.45M	1.95M	0.99M	1.01M	2.71M	7.50M	4.86M	27.11M	2.22M	1.60M	0.50M	3.53M	3.46M
Cash from Investing Activities (Quarter)	-138.00M	-954.19M	-355.05M	9.31M	-98.00M	-462.11M	-92.19M	44.38M	-168.62M	-76.61M	-79.56M	-238.37M	-85.79M	-61.87M	-21.32M	-76.10M	-45.48M	-37.34M	-33.70M	-92.81M
Financing Activities
Other financing activities (Quarter)		-2.33M	40.58M	0.00M	-1.87M	-15.54M	11.36M	-1.71M			-4.14M		-2.21M	-11.23M	-13.47M	-4.54M		-6.46M	-6.23M	-1.33M
Cash from Financing Activities (Quarter)	194.72M	517.96M	178.90M	-218.97M	-13.28M	271.44M	-51.59M	-248.96M	25.24M	-71.46M	-162.87M	123.57M	18.35M	-285.86M	-207.54M	-75.88M	-105.33M	-226.92M	-152.62M	-51.86M
Additional items
Exchange Rate Effect (Quarter)	10.95M	6.11M	0.45M	0.22M	5.74M	5.02M	-0.03M	14.85M	1.67M	-0.16M	-6.19M	12.72M	-8.39M	-3.34M	7.70M	-13.45M	5.26M	12.67M	-3.03M	3.93M
Change in Cash (Quarter)	237.91M	-243.53M	-0.98M	19.81M	-2.92M	-36.19M	-11.03M	45.04M	-32.32M	-0.11M	-43.16M	118.86M	54.05M	-157.53M	30.64M	-6.07M	26.16M	-46.99M	24.48M	6.78M
Free Cash Flow (Quarter)	142.20M	140.16M	119.19M	130.48M	22.17M	66.62M	60.39M	145.73M	2.51M	80.74M	139.50M	142.62M	50.74M	154.05M	213.07M	83.75M	112.37M	169.31M	178.25M	58.57M
Net Cash Flow (Quarter)	226.95M	-249.65M	-1.43M	19.59M	-8.66M	-41.20M	-11.00M	30.18M	-33.99M	0.05M	-36.97M	106.14M	62.44M	-154.19M	22.93M	7.38M	20.89M	-59.66M	27.51M	2.85M

Research Tools

Charles River Laboratories International Cash Flow Statement (2009-2025) | CRL

Create an account

Sign In

Reset Password